First Trust Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-29,611
| Closed | -$3.02M | – | 2530 |
|
|
2023
Q2 | $3.02M | Buy |
+29,611
| New | +$3.02M | ﹤0.01% | 1499 |
|
|
2021
Q4 | – | Sell |
-3,946
| Closed | -$397K | – | 2624 |
|
|
2021
Q3 | $397K | Buy |
+3,946
| New | +$397K | ﹤0.01% | 2333 |
|
|
2020
Q3 | – | Sell |
-7,810
| Closed | -$1.22M | – | 2522 |
|
|
2020
Q2 | $1.22M | Sell |
7,810
-23,870
| -75% | -$3.73M | ﹤0.01% | 1640 |
|
|
2020
Q1 | $4.57M | Sell |
31,680
-18,336
| -37% | -$2.65M | 0.01% | 900 |
|
|
2019
Q4 | $10.2M | Sell |
50,016
-8,220
| -14% | -$1.68M | 0.02% | 843 |
|
|
2019
Q3 | $4.68M | Buy |
58,236
+6,319
| +12% | +$507K | 0.01% | 1091 |
|
|
2019
Q2 | $4.9M | Buy |
51,917
+26,441
| +104% | +$2.49M | 0.01% | 1064 |
|
|
2019
Q1 | $2.18M | Sell |
25,476
-21,722
| -46% | -$1.86M | ﹤0.01% | 1510 |
|
|
2018
Q4 | $2.65M | Buy |
47,198
+43,976
| +1,365% | +$2.47M | 0.01% | 1312 |
|
|
2018
Q3 | $263K | Buy |
+3,222
| New | +$263K | ﹤0.01% | 2333 |
|